T. McCaffrey

Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex

F. Welt, T. McCaffrey, C. Brayton, 1989, The Journal of cell biology.

Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II Receptor*

K. Kent, T. McCaffrey, T. Collins, 2000, The Journal of Biological Chemistry.

Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

T. McCaffrey, T. Sanborn, T A Sanborn, 1995, The Journal of clinical investigation.

Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity

T. McCaffrey, B. Weksler, A. C. Nicholson, 1988, The Journal of experimental medicine.

Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.

T. McCaffrey, E. Vaughan, D. Felsen, 1996, Laboratory investigation; a journal of technical methods and pathology.

Glucocorticoid resistance caused by reduced expression of the glucocorticoid receptor in cells from human vascular lesions.

B. Du, T. McCaffrey, Paula J. Bray, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries.

Artur, T. McCaffrey, K. Kivirikko, 1995, The Journal of clinical investigation.

Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.

T. McCaffrey, C. Brayton, B. Weksler, 1992, Biochemical and biophysical research communications.